Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Common Stock | Tax liability | -$842 K | -19.9 K | -10.96% | $42.38 | 162 K | Feb 22, 2023 | Direct | F1 |
holding | PFE | Common Stock | 1.74 K | Feb 22, 2023 | By Rule 16b-3 Plan |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Stock Appreciation Rights | Award | $0 | +80.4 K | $0.00 | 80.4 K | Feb 23, 2023 | Common Stock | 80.4 K | $42.30 | Direct | F2 | |
transaction | PFE | Stock Appreciation Rights | Award | $0 | +69.9 K | $0.00 | 69.9 K | Feb 23, 2023 | Common Stock | 69.9 K | $42.30 | Direct | F3 |
Id | Content |
---|---|
F1 | The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon). |
F2 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
F3 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |